Biodegradable Microparticles for Regenerative Medicine: A State of the Art and Trends to Clinical Application
- PMID: 35406187
- PMCID: PMC9003224
- DOI: 10.3390/polym14071314
Biodegradable Microparticles for Regenerative Medicine: A State of the Art and Trends to Clinical Application
Erratum in
-
Correction: Sherstneva et al. Biodegradable Microparticles for Regenerative Medicine: A State of the Art and Trends to Clinical Application. Polymers 2022, 14, 1314.Polymers (Basel). 2025 Feb 26;17(5):622. doi: 10.3390/polym17050622. Polymers (Basel). 2025. PMID: 40076199 Free PMC article.
Abstract
Tissue engineering and cell therapy are very attractive in terms of potential applications but remain quite challenging regarding the clinical aspects. Amongst the different strategies proposed to facilitate their implementation in clinical practices, biodegradable microparticles have shown promising outcomes with several advantages and potentialities. This critical review aims to establish a survey of the most relevant materials and processing techniques to prepare these micro vehicles. Special attention will be paid to their main potential applications, considering the regulatory constraints and the relative easiness to implement their production at an industrial level to better evaluate their application in clinical practices.
Keywords: biomaterials; clinical application; drug delivery; emulsions; microparticles; regenerative medicine; scaffolds; tissue engineering.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures






References
-
- Zhu M., Whittaker A.K., Han F.Y., Smith M.T. Journey to the Market: The Evolution of Biodegradable Drug Delivery Systems. Appl. Sci. 2022;12:935. doi: 10.3390/app12020935. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources